BioCentury
ARTICLE | Clinical News

Bexsero regulatory update

August 19, 2013 7:00 AM UTC

Novartis said Australia's Therapeutic Goods Administration ( TGA) approved Bexsero to vaccinate against meningococcal disease in individuals aged >=2 months. Novartis plans to launch the multi-compone...